Hypotalmo-pituitary-adrenal axis dysfunction as a contributory factor to chronic pain and depression

被引:87
作者
Blackburn-Munro G. [1 ]
机构
[1] Department of Pharmacology, NeuroSearch A/S, DK-2750 Ballerup
关键词
Chronic Pain; Neuropathic Pain; Fibromyalgia; Dorsal Horn; Chronic Fatigue Syndrome;
D O I
10.1007/s11916-004-0025-9
中图分类号
学科分类号
摘要
Chronic pain and depressive illness are variably resistant to treatment with current pharmacologic therapies. Pain as a reflex sensory response is accompanied by a fast autonomic and delayed neuroendocrine response mediated by the sympathoadrenal and hypothalamo-pituitary-adrenal (HPA) axis, respectively. The emotional aspect of the pain response is encoded by corticolimbic systems (including the HPA axis) to encapsulate the relationship between pain, memory, and mood. These same systems contribute to the symptomatology of depression, a common symptom of which is pain. Conversely, many chronic pain patients may suffer from depressive illness, which appears to develop as a consequence of chronic pain. A comparison of key changes in HPA function after chronic stress in animals with clinical depression in humans, reveals some striking similarities. In this article, the role of the HPA axis in the etiology of chronic pain and depression is discussed. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:116 / 124
页数:8
相关论文
共 66 条
[21]  
Backonja M., Anticonvulsants and antiarrhythmics in the treatment of neuropathic pain syndromes, Neuropathic Pain: Pathophysiology and Treatment, pp. 185-201, (2001)
[22]  
Sindrup S.H., Jensen T.S., Antidepressants in the treatment of neuropathic pain, Neuropathic Pain: Pathophysiology and Treatment, pp. 169-183, (2001)
[23]  
Gold P.W., Chrousos G.P., Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low CRH/NE states, Mol. Psychiatry, 7, pp. 254-275, (2002)
[24]  
Herman J.P., Cullman W.E., Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis, Trends Neurosci., 20, pp. 78-84, (1997)
[25]  
Willner P., Mitchell P.J., The validity of animal models of pre-disposition to depression, Behav. Pharmacol., 13, pp. 169-188, (2002)
[26]  
Koehl M., Darnaudery M., Dulluc J., Et al., Prenatal stress alters circadian activity of hypothalamo-pituitary-adrenal axis and hippocampal corticosteroid receptors in adult rats of both gender, J. Neurobiol., 40, pp. 302-315, (1999)
[27]  
Nyirenda M.J., Welberg L.A., Seckl J.R., Programming hyperglycemia in the rat through prenatal exposure to glucocorticoids: Fetal effect or maternal influence?, J. Endocrinol., 170, pp. 653-660, (2001)
[28]  
Alonso S.J., Castellano M.A., Quintero M., Et al., Action of antidepressant drugs on maternal stress-induced hypoactivity in female rats, Methods Find Exp. Clin. Pharmacol., 21, pp. 291-295, (1999)
[29]  
Ward H.E., Johnson E.A., Salm A.K., Et al., Effects of prenatal stress on defensive withdrawal behavior and corticotrophin-releasing factor systems in rat brain, Physiol. Behav., 70, pp. 359-366, (2000)
[30]  
Plotsky P.M., Meaney M.J., Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats, Mol. Brain Res., 18, pp. 195-200, (1993)